Task: Answer the multiple choice question.
Query: Which drug exhibits a 4.463\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a: COc1ccc(OC)c(C(=O)CSc2nc3cccnc3n2C)c1
b: CCOC(=O)[C@@H]1[C@H]2COc3ccccc3[C@H]2N2C(=O)N(c3ccccc3)C(=O)[C@]12C
c: Cc1ccc(S(=O)(=O)N2CCN(C(=O)c3ccc(-n4cncn4)c([N+](=O)[O-])c3)CC2)cc1
d: CC(C)NC(=O)Cn1c(SCC(=O)NC2CCCC2)nc2ccccc21
Answer: d. CC(C)NC(=O)Cn1c(SCC(=O)NC2CCCC2)nc2ccccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)NC(=O)Cn1c(SCC(=O)NC2CCCC2)nc2ccccc21
CC(C)NC(=O)Cn1c(SCC(=O)NC2CCCC2)nc2ccccc21
2-[2-[2-(cyclopentylamino)-2-oxoethyl]sulfanylbenzimidazol-1-yl]-N-propan-2-ylacetamide